Presentation is loading. Please wait.

Presentation is loading. Please wait.

PREPARATION FOR FDA INSPECTION

Similar presentations


Presentation on theme: "PREPARATION FOR FDA INSPECTION"— Presentation transcript:

1 PREPARATION FOR FDA INSPECTION
NEMA/ADVAMED/PHILIPS September 25, 2003 Robert L. Turocy

2 INSPECTION CYCLE PRE-INSPECTION INSPECTION POST-INSPECTION

3 FDA REQUESTS INSPECTION
TELEPHONE CALL DATE IDENTIFIED REQUEST FOR DOCUMENTATION FACILITY CONTACT

4 PRE-INSPECTION PLAN INSPECTION, OBJECTIVES ASSIGN COORDINATOR
INSPECTION SCOPE & REGULATIONS REVIEW PROCEDURES REVIEW PAST INSPECTIONS DOCUMENTATION SUPPLIED SCHEDULING, PERSONNEL, & FACILITIES PREPARATION TRAINING

5 PRE-INSPECTION CONT. GENERATE LOG TOP PRIORITY FDA NEEDS
INSPECTION TYPE INTERPERTER MOCK INSPECTION

6 PRE-INSPECTION CONT. REVIEW QM & POLICY ACTIVITIES ASSIGNED ALTERNATES
COMMUNICATION

7 FDA ACCESS MEDICAL DEVICE TRAINING RECORDS MATERIALS PACKAGING
LABELING EQUIPMENT LOCATION REGISTRATION & LISTING FACILITIES

8 FDA ACCESS cont. SAMPLES PRODUCTION RECORDS CHANGE CONTROL
COMPLAINT FILES SHIPPING RECORDS DMR DHR MDR AND C&R

9 REFUSE FDA ACCESS FINANCIAL DATA SALES VALUES PRICING PERSONNEL DATA
MANAGEMENT REVIEWS INTERNAL AUDITS SUPPLIER AUDITS

10 INSPECTION OPENING MEETING REQUEST ID INTRODUCTION SCOPE
DAILY MEETINGS REVIEW FINDINGS & OBSERVATIONS CHANGES CORRECTIONS

11 INSPECTION CONT. CLOSING MEETING ATTENDEES SUMMARY FDA 483
CLARIFY ISSUES IMMEDIATE CA VERBAL CORRECTION CA PLAN MANAGEMENT

12 POST-INSPECTION ASSIGNEMENTS REVISIONS REPORT TO MGT IMPLEMENT CA
RESPOND TO FDA FDA RESPONSE

13 POST-INSPECTION cont. FOLLOW-UP OTHER REGULATORY ACTION IMPROVEMENT
EIR

14 INSPECTION DOs DO PLAN FOR INSPECTION
DO PROVIDE REVELANT DOCUMENTATION DO ANSWER QUESTIONS TO SPECIFIC ACTIVITY DO ESCORT THE INSPECTOR DO TAKE NOTES DO COPY DOCUMENTS REMOVED DO STAMP THE REMOVE DOCUMENTS DO COOPERATE WITH THE FDA BE POLITE BUT FIRM WITH YOUR RIGHTS

15 INSPECTION DON’Ts DON’T OVER SPEAK OR SAY IT’S IMPOSSIBLE
DON’T ALLOW RECORDINGS DON’T SIGN AFFIDAVITS DON’T ALLOW ACCESS TO FILES DON’T GUESS AT AN ANSWER DON’T ANSWER “WHAT IF ?” DON’T ENGAGE IN ARGUMENT

16 REFERENCES 21 CFR 820, Preamble & Regulation
INSP. DEVICE MFGRS. CP FDA QSIT HANDBOOK GUIDE ADVAMED POINTS TO CONSIDER MGMT, DESIGN, & CAPA

17


Download ppt "PREPARATION FOR FDA INSPECTION"

Similar presentations


Ads by Google